THRX up +1.57% percent Today $THRX High is at 13.61 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 1:59 PM

THRX up +1.57% percent Today $THRX High is at 13.61 and the Low 13.17 with current volume of 79,966.

Recent News posted below.

Theravance THRX other info.
http://investorshangout.com/Theravance-THRX-55637/

THRX Theravance Recent Headline News

Patient recruitment complete in "real-world" COPD study
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 7:32AM CST

THRX: 13.58 (+0.23), GSK: 46.41 (+0.13)

Theravance Earnings Review: 18 Days after Announcement Shares Down 18.4% (THRX)
Comtex SmarTrend(R) - Mon Nov 17, 4:04PM CST
When Theravance (NASDAQ:THRX) reported earnings two weeks ago on October 30th, 2014, analysts, on average, expected the company to report a loss of $0.13 on sales of $6.9 million. Theravance actually reported a loss of $0.19 per share on sales of $999.0 thousand, missing EPS estimates by $0.06 and missing revenue estimates by $5.9 million. Shares of Theravance have slipped from $16.21 to $13.23, representing a loss of 18.4%, since the company reported earnings 18 days ago.
THRX: 13.58 (+0.23)

Tracking Seth Klarman's Baupost Group Holdings - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 9:14AM CST

OCN: 21.24 (+0.19), KOS: 9.44 (+0.05), KIN: 8.96 (+0.05), VSAT: 65.64 (+0.10), RFMD: 13.69 (-0.06), EBAY: 55.03 (-0.35), TQNT: 22.85 (-0.08), IDIX: 24.50 (+0.05), SEMI: 16.65 (-0.01), VRTV: 50.69 (+2.30), THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), IMOS: 20.70 (-0.91), ELOS: 9.90 (-0.03), MU: 32.75 (-0.12), AR: 52.98 (+0.83), NCQ: 0.69 (unch), PBF: 28.38 (+0.72), LNG: 72.71 (+0.95), ATRA: 26.63 (+0.28), KERX: 15.26 (-0.28), NG: 2.95 (-0.08), AOI: 1.89 (-0.01), FWP: 21.39 (+0.25), BYD: 11.70 (-0.04), ALDW: 17.67 (+0.11), SUNE: 21.39 (-0.09), MRK: 59.55 (-0.34), AVEO: 0.99 (+0.04), AIG: 54.03 (+0.14)

Update: Theravance Reveals Interesting Bits Of Information At CS Conference
Early Retiree - at Seeking Alpha - Fri Nov 14, 10:53AM CST

THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), GSK: 46.41 (+0.13)

Shares of THRX Down 51.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 14, 9:38AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 51.85% as of today's recent price of $13.16.
THRX: 13.58 (+0.23)

Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 2:38PM CST

THRX: 13.58 (+0.23)

When Is It Time To Accumulate Theravance?
Chris Lau - at Seeking Alpha - Tue Nov 11, 10:50AM CST

MRK: 59.55 (-0.34), AZN: 75.42 (+1.44), THRX: 13.58 (+0.23), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12)

Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:44AM CST

MRK: 59.55 (-0.34), AZN: 75.42 (+1.44), AMGN: 162.74 (+0.50), TEVA: 57.22 (-0.01), THRX: 13.58 (+0.23), GSK: 46.40 (+0.12), SNY: 48.34 (-0.02), REGN: 416.75 (+3.53), NVS: 95.75 (+0.17)

Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:20AM CST
Theravance Biopharma reported a third-quarter 2014 loss of $1.72 per share.
AMAG: 35.69 (+0.35), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23)

Shares of THRX Down 47.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:10AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 47.93% as of today's recent price of $14.23.
THRX: 13.58 (+0.23)

5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More
at The Street - Thu Nov 06, 11:45AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
SCCO: 29.83 (-0.49), WRLD: 78.19 (+1.12), NS: 59.40 (-0.40), THRX: 13.58 (+0.23), HUN: 26.02 (-0.31)

Theravance to Present at Two Upcoming Investor Conferences in November
Marketwired - Wed Nov 05, 3:08PM CST
Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November.
THRXV: 28.00 (+7.07), THRX: 13.58 (+0.23)

Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 35.52 (+0.22), TJX: 61.84 (+0.20), NKE: 97.00 (+0.53), TGT: 72.12 (+4.61), WMT: 85.13 (+1.34), HBI: 111.75 (+1.32), THRX: 13.58 (+0.23), KORS: 72.87 (-0.06), GPS: 39.40 (+0.05), RL: 178.76 (+2.20), LULU: 45.50 (+0.70)

InsiderInsights.com Daily Round Up 11/4/14: UFI, SABA, CCI
InsiderInsights - at Seeking Alpha - Wed Nov 05, 8:31AM CST

CCI: 80.67 (+0.15), CBG: 32.94 (-0.20), HGG: 6.11 (+0.07), LLY: 67.11 (-0.67), BA: 132.01 (+1.35), MAR: 76.73 (-0.21), QNST: 4.31 (-0.09), OZRK: 35.95 (+0.08), APO: 23.04 (-0.30), STAA: 8.69 (-0.01), AMBR: 11.19 (-0.05), FSAM: 14.53 (-0.23), WRLD: 78.19 (+1.12), CPLA: 69.38 (+0.59), THRX: 13.58 (+0.23), MSFT: 48.16 (-0.58), UFI: 27.29 (+0.17), AN: 58.23 (+0.50), CRM: 61.36 (-1.11)

FDA accepts BI's Spiriva NDA for asthma
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:06PM CST

AZN: 75.42 (+1.44), TEVA: 57.22 (-0.01), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23), SNY: 48.34 (-0.02), REGN: 416.75 (+3.53), NVS: 95.75 (+0.17)

7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST

KND: 20.53 (+0.53), VIVO: 16.04 (-0.10), PETS: 13.35 (-0.15), PFE: 30.37 (-0.22), GSK: 46.40 (+0.12), MR: 30.93 (+0.17), SEM: 13.78 (-0.06), PDLI: 7.94 (-0.03), SNN: 34.14 (+0.36), AZN: 75.42 (+1.44), MRK: 59.55 (-0.34), STJ: 63.84 (-1.11), TRIB: 17.10 (-0.15), ABBV: 65.59 (-0.46), THRX: 13.58 (+0.23), SNY: 48.34 (-0.02)

Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:10AM CST
Theravance reported third-quarter 2014 loss of 19 cents per share.
AMAG: 35.69 (+0.35), TBPH: 16.50 (+0.04), GSK: 46.40 (+0.12), THRX: 13.58 (+0.23)

Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:00AM CST
Bayer's (BAYRY) earnings during the third quarter of 2014 came in at roughly $1.79 per share.
MRK: 59.55 (-0.34), AMAG: 35.69 (+0.35), THRX: 13.58 (+0.23)

Update: GSK Starts Promoting Theravance Drugs More Actively
Early Retiree - at Seeking Alpha - Sat Nov 01, 7:42AM CDT

THRX: 13.58 (+0.23), GSK: 46.40 (+0.12)

More on Theravance Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:03PM CDT

THRX: 13.58 (+0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stronghold's Unfulfilled Promise May Cost Coachella Millions

Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...

Max Stock Expands with Strategic Logistics Center

Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...

October 15 Marks Prologis Q3 2026 Results Call

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Curaleaf Eyes Growth: Conference Signals Opportunities

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Travel Smart: Support Wildlife, Avoid Exploitation

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Honoring Dr. Drew's Impact on Blood Banking History

Legacy of Dr. Charles R. Drew Comes Alive Here's one for the books: a legacy that's still saving lives 85 years after it began. Dr. Charles R. Drew, the mastermind behind blood banking, is getting his due respect with a documentary called Iconic Excellence. No fluff here—this film unveils how the man's breakthroughs during World War II laid down the bedrock of modern...

FirstEnergy's Bold Move: Dormo Joins to Boost Power

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Post-Facial Care: Extend Benefits Beyond the Spa

The Day After a Facial Is Just as Crucial If you’re thinking a facial ends when you walk out of the spa, you’re dead wrong. Valen Perez, the driving force behind Picture Perfect Esthetics LLC in Fayetteville, NC, breaks it down in HelloNation: the glow-wielding magic of a facial needs the right follow-up to really shine. You spend that cash on a pro facial, but...

Taiwan's Machine Emerges as Heavy-Tonnage Game Changer

Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...